Urologix, Inc.
ULGX
$0.0001
$0.000.00%
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Revenue | 12.00M | 12.55M | 13.27M | 14.01M | 14.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.00M | 12.55M | 13.27M | 14.01M | 14.89M |
| Cost of Revenue | 6.37M | 7.39M | 7.78M | 8.14M | 8.44M |
| Gross Profit | 5.63M | 5.16M | 5.48M | 5.87M | 6.45M |
| SG&A Expenses | 5.15M | 5.89M | 6.93M | 8.17M | 9.11M |
| Depreciation & Amortization | 79.00K | 91.00K | 96.00K | 96.00K | 99.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.91M | 14.79M | 16.35M | 18.03M | 19.44M |
| Operating Income | -915.00K | -2.24M | -3.08M | -4.01M | -4.55M |
| Income Before Tax | -4.72M | -6.02M | -6.73M | -7.62M | -5.32M |
| Income Tax Expenses | -53.00K | -35.00K | -23.00K | -16.00K | 12.00K |
| Earnings from Continuing Operations | -4.67 | -5.98 | -6.71 | -7.61 | -5.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.67M | -5.98M | -6.71M | -7.61M | -5.33M |
| EBIT | -915.00K | -2.24M | -3.08M | -4.01M | -4.55M |
| EBITDA | -414.00K | -1.71M | -2.52M | -3.43M | -3.94M |
| EPS Basic | -0.22 | -0.28 | -0.31 | -0.36 | -0.25 |
| Normalized Basic EPS | -0.05 | -0.09 | -0.11 | -0.14 | -0.16 |
| EPS Diluted | -0.23 | -0.29 | -0.32 | -0.36 | -0.25 |
| Normalized Diluted EPS | -0.05 | -0.09 | -0.11 | -0.14 | -0.16 |
| Average Basic Shares Outstanding | 86.41M | 85.89M | 85.36M | 84.89M | 84.50M |
| Average Diluted Shares Outstanding | 86.41M | 85.89M | 85.36M | 84.89M | 84.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
